Company Overview of Applied Immune Technologies Ltd.
Applied Immune Technologies Ltd. engages in the development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications in pathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Gutwirth Industrial Park
Founded in 2006
972 4 8122216
972 4 8122294
Key Executives for Applied Immune Technologies Ltd.
Similar Private Companies By Industry
|Spearhead Investments (Bio) Ltd.||Middle East/Africa|
|Juvenis Ltd.||Middle East/Africa|
|Immunovative Therapies Ltd.||Middle East/Africa|
|Meditor Pharmaceuticals Ltd.||Middle East/Africa|
|Tissera Inc.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- St Louis, MO | Nova BiomedicalPosted: Apr 07
- San Francisco, CA | Investment Firm Providing Private and Institutional BrokeragePosted: Apr 07
- Kansas City, MO | SkillsniperPosted: Apr 14
- New York | Leading Financial Institution of CanadaPosted: Mar 05
Sponsored Financial Commentaries
To contact Applied Immune Technologies Ltd., please visit www.tcrl.co.il. Company data is provided by Capital IQ. Please use this form to report any data issues.